CONMED Corp — Director's Dealing 2020

Dec 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2020-12-15

Reporting Person: Cohen Heather L (EVP CORP HR)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-15	Common Stock	M	5000	$27.63	Acquired	24328	Direct
2020-12-15	Common Stock	F	2530	$109.73	Disposed	21798	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-15	Sars (Stock Appreciation Rights)	$27.63	M	5000	Disposed	2021-06-01	Common Stock (5000)	Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.